Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors. - Chin TM; Boopathy GTK; Man EPS; Clohessy JG; Csizmadia E; Quinlan MP; Putti T; Wan SC; Xie C; Ali A; Wai FC; Ong YS; et al. (Theranostics, 2020)